Pay in 4 interest-free payments of $6.58 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
What Our Patients Say The monthly follow-ups and lab monitoring gave me confidence that I was losing weight safely
Key characteristics of Ipamorelin include: Selective action on growth hormone release Short half-life of approximately 2 hours Clean safety profile with minimal side effects How these peptides work together The synergy between CJC-1295 and Ipamorelin creates a powerful combination that maximizes growth hormone production through complementary mechanisms: When prescribed together, these peptides typically produce a 3-5 fold increase in growth hormone release compared to using either compound alone
Divi, Whole-Time Director & CEO, Divis Laboratories | Q2 FY26 The trade-off is clean
It's a truth our team at Real Peptides lives by
Do you think of them as good for us, or as bad for us
adults currently take a GLP-1 for weight loss (up from 3 percent in 2024 and 8 percent in 2025) 15 percent have used a GLP-1 medication for weight loss at some point 68 percent of current users take brand-name medications such as Ozempic, Wegovy, or Zepbound 19 percent take compounded or custom-mixed GLP-1 versions not approved by the FDA 91 percent of Americans now know GLP-1 drugs can be used for weight loss (up from 80 percent in 2024) The Medicare GLP-1 Bridge, administered by the Centers for Medicare and Medicaid Services (CMS), is a demonstration program operating outside the standard Part D benefit
